Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

29.10
Delayed Data
As of Mar 27
 +0.28 / +0.97%
Today’s Change
24.47
Today|||52-Week Range
41.91
-11.39%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues111.0M101.5M142.9M151.7M
 
 
 
 
 
Cost of Goods Sold18.9M26.6M28.8M40.3M
 
 
 
 
 
Depreciation And Amortization8.8M8.9M10.4M10.1M
 
 
 
 
 
 
Operating ExpensesGross Income83.2M66.0M103.7M101.3M
 
 
 
 
 
General Expenses73.8M79.5M67.9M62.5M
 
 
 
 
 
Research And Development34.1M35.3M27.2M27.1M
 
 
 
 
 
Total Operating Expenses101.6M115.0M107.1M112.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income9.4M-13.5M35.8M38.8M
 
 
 
 
 
Extraordinary Credit0.000.000.0012.1M
 
 
Extraordinary Charge-847.0K-88.0K-328.0K0.00
 
 
 
 
Interest Expense On Debt2.3M2.3M2.3M2.9M
 
 
 
 
 
Other Expenses116.0K17.0K-234.0K439.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income7.3M-14.9M33.6M49.1M
 
 
 
 
 
Income Taxes-3.3M-3.9M-13.2M-16.8M
 
 
 
 
 
Discontinued Operations0.000.00952.0K5.1M
 
 
 
Net Income4.0M-10.9M21.3M37.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS39.5M40.2M40.5M40.5M
 
 
 
 
 
Shares To Calculate EPS Diluted48.4M40.2M49.4M49.6M
 
 
 
 
 
 
Earnings Per ShareEPS$0.10-$0.27$0.45$0.77
 
 
 
 
 
EPS Diluted$0.10-$0.27$0.45$0.78